Please use this identifier to cite or link to this item:
https://doi.org/10.1172/JCI62884
Title: | New approaches under development: cardiovascular embryology applied to heart disease | Authors: | Degenhardt, Karl Singh, Manvendra K Epstein, Jonathan A |
Keywords: | Science & Technology Life Sciences & Biomedicine Medicine, Research & Experimental Research & Experimental Medicine BETA 4 TREATMENT MYOCARDIAL-INFARCTION CARDIAC FIBROBLASTS STEM-CELLS EPICARDIUM MOUSE INJURY DIFFERENTIATION CARDIOMYOCYTES PROLIFERATION |
Issue Date: | 1-Jan-2013 | Publisher: | AMER SOC CLINICAL INVESTIGATION INC | Citation: | Degenhardt, Karl, Singh, Manvendra K, Epstein, Jonathan A (2013-01-01). New approaches under development: cardiovascular embryology applied to heart disease. JOURNAL OF CLINICAL INVESTIGATION 123 (1) : 71-74. ScholarBank@NUS Repository. https://doi.org/10.1172/JCI62884 | Abstract: | Despite many innovative advances in cardiology over the past 50 years, heart disease remains a major killer. The steady progress that continues to be made in diagnostics and therapeutics is offset by the cardiovascular consequences of the growing epidemics of obesity and diabetes. Truly innovative approaches on the horizon have been greatly influenced by new insights in cardiovascular development. In particular, research in stem cell biology, the cardiomyocyte lineage, and the interactions of the myocardium and epicardium have opened the door to new approaches for healing the injured heart. | Source Title: | JOURNAL OF CLINICAL INVESTIGATION | URI: | https://scholarbank.nus.edu.sg/handle/10635/201229 | ISSN: | 00219738 15588238 |
DOI: | 10.1172/JCI62884 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
2013. Degenhardt et al. Journal of Clinical Investigation.pdf | Published version | 464.59 kB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.